Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
- HIV / AIDs
- Bacterial Infection
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 197787
IPSCIO Record ID: 365949
(a) an exclusive (even as to Licensor), perpetual non-transferable license, with right to grant and authorize sublicenses solely under the Licensed IP and the Licensor Trademarks for Licensee to Develop and Commercialize Products in the Licensee Territory; and; (b) a non-exclusive, non-transferable license, with right to grant and authorize sublicenses (to a contract manufacturer only) solely under the Licensed IP for Licensee to Manufacture or have Manufactured Products for Commercialization in the Licensee Territory, including the right to Manufacture Crofelemer and Lechlemer; provided, however, that during the Term, Licensee shall only be entitled to utilize its license to Manufacture or have Manufactured Products to the extent provided.
US 8,962,680 – Methods and compositions for treating HIV-associated diarrhea
US 9,585,868 – Methods and compositions for treating HIV-associated diarrhea
US 8,846,113 – Method for treatment of diarrhea-predominant irritable bowel syndrome
Crofelemer is a naturally occurring botanical biopolymer extracted from the stem bark latex of the Croton lechleri tree. 1 It is an FDA-approved drug for the treatment of noninfectious diarrhea in adult patients with HIV/AIDS undergoing antiretroviral therapies and acts by inhibiting 2 chloride channels located in the gastrointestinal tract.
IPSCIO Record ID: 7614
Licensor may grant sublicenses of the licenses granted to Licensee in this Agreement to its Affiliates and Sublicensees.
(1) crofelemer (SP-303),
(2) normal stool formula (NSF),
(3) Nutraceutical (SB-300),
(4) any and all technology and information related to SP-303, NSF and SB-300, and any other product derived from, or containing an ingredient derived from, the crude plant latex of Croton lechleri owned by Licensor or to which Licensor had rights prior to July 1, 2005, NP-500,
(5) Licensorâ€™s natural product pipeline of tropical medicinal plants and extracts, and
(6) any and all technology and information related to Compounds, formulations, plants, and extracts, including methods of isolating, manufacturing, formulating or otherwise manipulating the Compounds, formulations, plants and extracts for therapeutic use, and methods of use of such Compounds, formulations, plants, and extracts.
â€œCompoundâ€ shall mean any pharmaceutical, or biological product (including any over-the-counter product), any standardized botanical extract or nutraceutical substance or product, or any food or dietary supplement or other natural product currently marketed or in development or to be developed in the Field of Use, and subject to the terms of this Agreement.
IPSCIO Record ID: 332244
Licensor hereby grants to Licensee an exclusive (including with regard to Licensor and its Affiliates), royalty-bearing license and right of reference, with the right to grant sublicenses and further rights of reference in accordance with this Agreement, under the Regulatory Documentation Controlled by Licensor or any of its Affiliates, if any, to Exploit the Licensed Compound or the Licensed Products in (a) the Human Excluding HIV/AIDS/ID/Pediatric Field in the Licensee Human Excluding HIV/AIDS/ID/Pediatric Territory; (b) the HIV/AIDS/Pediatric Field in the Licensee HIV/AIDS/Pediatric Territory; and (c) the ID Field in the Licensee ID Territory.
Licensor hereby grants to Licensee a non-exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses in accordance with this Agreement, to use the Product Trademarks (to the extent Controlled by Licensor) as necessary to exercise its rights under the grants in this Agreement, provided that Licensor shall have a right to monitor and comment upon the manner in which such Product Trademarks are used.
Licensed Product means any form or dosage of pharmaceutical composition or preparation in finished form labeled and packaged for sale by prescription, over-the-counter, dietary supplement, food or any other method that contains the Licensed Compound as an active ingredient (including a Licensed Product that contains the Licensed Compound as an active ingredient together with one or more other active ingredients (which may be either combined in a single formulation or bundled with separate formulations but sold as one product)), and any Improvements thereto.
5,211,944 – Proanthocyanidin polymers having antiviral activity and methods of obtaining same
5,494,661 – Methods for using proanthocyanidin polymers having antiviral activity
7,341,744 – Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
Product Trademarks shall mean all Trademarks for use with a Licensed Product designated in accordance with this Agreement and any registrations thereof or any pending applications relating thereto.
Trademark shall include any word, name, symbol, color, designation or device or any combination thereof, including any trademark, trade dress, brand mark, trade name, brand name, logo or business symbol, which in each case is specific to a Licensed Product. Notwithstanding anything in the foregoing, the term â€œTrademarkâ€ does not include any house marks, trade dress or logos of Licensee or its Affiliates.
Human Excluding HIV/AIDS/ID/Pediatric Field means all indications of the Licensed Compound for human use or consumption (including by way of food or dietary supplements), other than HIV/AIDS-related diarrhea, acute infectious diarrhea and pediatric diarrhea of any etiology including cholera; HIV/AIDS/Pediatric Field means only those indications of the Licensed Compound for human use for HIV/AIDS-related diarrhea and pediatric diarrhea; and ID Field means only those indications of the Licensed Compound for human use for acute infectious diarrhea, specifically including cholera and travelerâ€™s diarrhea. This also includes the ID Field and the HIV/AIDS/Pediatric Field.
IPSCIO Record ID: 266736
Licensor grants to the extent of the Licensed Territory a nonexclusive license to use the Licensed Technology as necessary to exploit all rights granted with respect to the patent rights in the Licensed Field, with the right to sublicense.
Rifaximin means rifaximin, any pharmaceutical equivalents, salts and derivatives thereof.
IPSCIO Record ID: 2810
Compound means 2-di-n-propylamino-8-(isoxazol-5-yl)-1,2,3,4-tetrahydronaphthalene and all pharmaceutically acceptable salts and solvates.
Gastrointestinal Indications means disease states, such as excess gastric acid secretion, inflammatory bowel disease, irritable bowel syndrome, gastroesophagael reflux disease, esophagitis, dyspepsia, proctitis, hemorrhoids, gastrointestinal ulceration, nausea and vomiting and constipation and diarrhea, which are characterized by abnormalities of the Digestive System, regardless of the mechanism involved in such disease states.